3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Interventions
Psychiatric Rehabilitation
6
Surveys and Questionnaires
5
Counseling
4
Therapeutics
3
Radiotherapy
3
Sildenafil Citrate
2
High-Intensity Focused Ultrasound Ablation
2
Exercise
2
trametinib
1
sotorasib
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
methyl N-acetylsibirosaminide
1
methyl 3-mercaptopropionimidate
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
brigatinib
1
bicalutamide
1
alectinib
1
Vitamin E
1
Vitamin D
1
Uterine Myomectomy
1
Testosterone Propionate
1
Testosterone
1
Tadalafil
1
Surgical Procedures, Operative
1
Sexual Health
1
Sex Education
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sexual Dysfunction, Physiological
×
Robotics
×
Other
×
Clear all
NCT03209076
2019-10-16
RAR
Instituto Nacional de Cancer, Brazil
Phase NA
Unknown
120 enrolled